Item 8.01 Other Events.

On January 27, 2022, PDS Biotechnology Corporation (the "Company") issued a press release announcing that preclinical data for its universal flu vaccine was shown to be effective against multiple strains of the influenza virus. A copy of the press release is filed as Exhibit 99.1 hereto and incorporated by reference herein.

On January 27, 2022, the Company updated its corporate presentation slide deck. A copy of the slide deck is filed as Exhibit 99.2 hereto and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.
Exhibit
 Number                                  Description

  99.1     Press Release January 27, 2022.
  99.2     Updated Corporate Presentation January 2022.
  104      Cover Page Interactive Data File - the cover page interactive date file
           does not appear in the Interactive Date File because its XBRL tags are
           embedded within the Inline XBRL document.

--------------------------------------------------------------------------------


                                   Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PDS BIOTECHNOLOGY CORPORATION

Date: January 27, 2022   By: /s/ Frank Bedu-Addo, Ph.D.


  Name: Frank Bedu-Addo, Ph.D.


  Title: President and Chief Executive Officer

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses